Aims To determine the impact of preventing new (incident) cases of coronary heart disease (CHD) on years of life and productivity, using the novel measure 'productivity-adjusted life year' (PALY), over the next 10 years.Savira, FebyWang, Bing H.Kompa, Andrew R.Ademi, ZanfinaOwen, Alice ...
Coronary Heart Disease: In this disease, the arteries of the patient, which carry blood from the heart, have a buildup of plaque. Plaque is a fatty, waxy substance that makes the arteries stiff. As more of it collects, the flow of blood becomes difficult and leads to the clotting of th...
Cardiovascular disease (CVD), including heart failure, ischemic heart disease, and stroke, are the most common causes of death in Canada [1]. Treatment of CVD accounts for the largest proportion of Canadian health care expenditures [1, 2]. It is estimated that the majority of CVD can be pr...
BackgroundFew data are available on the long-term impact of type 2 diabetes mellitus on total mortality and fatal coronary heart disease (CHD) in
Skip to main contentSkip to article Journals & Books Help Search My accountSign in View PDF Download full issue Search ScienceDirect
The Impact of the Androgen Deprivation Therapy on the Risk of Coronary Heart Disease in Patients with Non-Metastatic Prostate Cancer: A Population-Based ... Gandaglia,Popa 被引量: 0发表: 0年 Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from ...
There are only a few reports on the impact of hypertension on the lifetime risk of cardiovascular events. The Suita Study, a cohort study of urban residents, was established in 1989. We included all participants who were coronary heart disease (CHD) free at baseline. Age (in years) was ...
Coronary risk factors: their impact, and their therapy in the prevention of coronary heart disease. Med Clin North Am. 1966 Jan; 50 (1):229–254... J Stamler,DM Berkson,HA Lindberg,... - 《Medical Clinics of North America》 被引量: 79发表: 1966年 Risk factors of coronary heart dise...
Prior percutaneous coronary intervention 9.8% 13.9% 0.003 Prior CABG 2.3% 5.6% <0.0001 Killip class >1 7.3% 13.9% <0.0001 Anemia 8.2% 23.7% <0.0001 Peripheral artery disease 3.5% 9.2% <0.0001 History of congestive heart failure 5.1% 2.6% 0.001 Primary management strategy PCI 92.2% 93.2% 0....
How the Coronavirus Disease 2019 (COVID-19) pandemic has affected prevention and management of cardiovascular disease (CVD) is not fully understood. In this study, we used medication data as a proxy for CVD management using routinely collected, de-identi